SPNT insider purchase: Director acquires 3,698 restricted shares at $18.59

Rhea-AI Filing Summary

Martin Hudson, a director of SiriusPoint Ltd. (SPNT), acquired 3,698 common shares on 09/09/2025 at a price of $18.59 per share. The purchase increases his beneficial ownership to 3,698 shares and includes restricted shares that vest in full on May 30, 2026, subject to his continued service as a director. The transaction was reported on a Form 4 and was signed by an attorney-in-fact on the reporting statement.

Positive

• Director purchase of 3,698 shares at $18.59 indicates insider alignment with shareholder interests
• Restricted shares vesting on May 30, 2026 ties equity to continued board service

Negative

• None.

Insights

Financial Analyst

TL;DR: Director purchase of 3,698 shares at $18.59 shows insider buying but is small relative to typical market caps.

The reported acquisition consists of 3,698 common shares acquired at $18.59 each and includes restricted shares that vest on May 30, 2026 contingent on continued board service. This is a straightforward insider purchase with no complex derivative instruments or dispositions reported. For investors, the purchase signals insider alignment but is immaterial by itself unless aggregated with other insider activity or viewed relative to outstanding shares.

Corporate Governance Expert

TL;DR: Transaction reflects routine director equity compensation/holding with standard vesting conditions.

The Form 4 shows the beneficial owner is a director and that the shares include restricted stock that vests upon continued service. The filing indicates compliance with disclosure obligations and does not show any derivative exercises, sales, or other governance concerns. The vesting condition ties the equity to service tenure, a common governance mechanism to align directors with long-term performance.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hudson Martin Peter

(Last) (First) (Middle)

POINT BUILDING

3 WATERLOO LANE

(Street)

PEMBROKE D0 HM08

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SiriusPoint Ltd [ SPNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/09/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/09/2025		A		3,698(1)	A	$18.59	3,698(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes restricted shares that vest in full on May 30, 2026, subject to the Reporting Person's continued service as a director of the Company.

2. Includes Restricted Shares.

Remarks:

	/s/Naveen Gurudevan, Attorney-in-Fact for Martin Hudson	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did SiriusPoint (SPNT) director Martin Hudson report on the Form 4?

He reported acquiring 3,698 common shares at $18.59 per share, increasing his beneficial ownership to 3,698 shares.

When were the shares acquired according to the Form 4 for SPNT?

The transaction date listed is 09/09/2025.

Are any of the shares subject to vesting or restrictions?

Yes. The Form 4 states the reported shares include restricted shares that vest in full on May 30, 2026, subject to continued service as a director.

Did the Form 4 report any derivative transactions or sales for SPNT?

No. The filing lists only a non-derivative acquisition of common shares and shows no derivative securities or dispositions.

Who signed the Form 4 report for Martin Hudson?

The Form 4 was signed by an attorney-in-fact, Naveen Gurudevan.